BSE filing, NSE: INTERARCH. Summary written from the filing by ALFA Finder's alert engine.
Interarch Building Solutions Ltd: key numbers
- Share price
- ₹1,499.80
- Market cap
- ₹2,522 Cr
- Revenue (annual)
- ₹1,898 Cr
- Net profit (annual)
- ₹134.5 Cr
- P/E (TTM)
- 18.8×Sector 31.3×
- Promoter holding
- 59.27%-0.16% QoQ
- FII holding
- 4.90%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Interarch Building Solutions Ltd
All →Interarch Building Solutions Board Meeting Date
Interarch Building Solutions Limited intimates a board meeting on 4 November 2026 to consider unaudited standalone half-yearly results for September 2026. Trading window closes from 1 October 2026.
Interarch Building Solutions Stock Split
Interarch fixed November 30, 2026 as Record Date for its 1:5 equity share split. Each Rs.10 face-value share becomes five Rs.2 shares.
Interarch Building Solutions Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI (LODR) Regulations.
Interarch Building Solutions Management Change
Interarch Building Solutions Limited announced the cessation of Mr. Anil Kumar Chandani as President-Corporate Finance & Strategy, effective October 14, 2026, due to superannuation.
Interarch Building Solutions Bags ₹59 Cr Order
Interarch Building Solutions received a ~₹59 Crore order for a Pre-Engineered Steel Building in South India. Execution is approximately 10 months with 25% advance payment terms.
- Value
- ₹59.00 Cr
- Execution
- Approx. 10 months
Interarch Building Solutions Bags ₹61 Cr Order
Interarch received a Rs.61 Crore order for a Pre-Engineered Steel Building System for a Copper Refinery in Gujarat. Delivery is expected within 12 months with 20% advance.
- Value
- ₹61.00 Cr
- Execution
- Approx. 12 months
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date